Catheter Precision, Inc. Announces Initial LockeT Purchase From the University of Tennessee Medical Center
Portfolio Pulse from
Catheter Precision, Inc. (NYSE American: VTAK) has received its first purchase order for its product LockeT from the University of Tennessee Medical Center. This follows the company's expansion of its US sales and clinical team in preparation for a national launch.
January 13, 2025 | 1:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Catheter Precision, Inc. has secured its first purchase order for LockeT, indicating positive momentum towards its national launch. This could boost investor confidence and potentially increase revenues.
The first purchase order for LockeT is a significant milestone for Catheter Precision, Inc., suggesting successful market entry and potential revenue growth. The expansion of the sales and clinical team further supports the company's growth strategy, likely leading to positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100